Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05821205 · ClinicalTrials.gov registry record · NA
Michigan Youth Violence Prevention Center: Building Evidence for Gun Violence Prevention - SafERteens Implementation
A NA study of Violence in Adolescence, sponsored by University of Michigan.
- Recruiting
- Registry status
- NA
- Development phase
- 240
- Enrollment target
- 8
- Study locations
NCT05821205: Recruiting NA study of Violence in Adolescence, sponsored by University of Michigan.
NCT05821205 is a NA study of Violence in Adolescence that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 240 participants, below the 756-participant average among 9 other Violence in Adolescence trials with a reported enrollment target (68% lower). The trial reports 8 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05821205, a NA study of Violence in Adolescence, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of this study is to determine the preliminary efficacy (via a micro-randomized trial \[MRT\] design) of augmenting Enhanced-Replicating Effective Program (E-REP) with engagement strategies to increase and sustain reach by healthcare providers (e.g., nurses, social workers) during implementation of the SafERteens program across multiple healthcare settings.
Primary Outcome
Reach is defined as the number of participants screened or the number of participants to whom the intervention was delivered. The researchers hypothesize that during weeks where providers receive an engagement strategy (ES), reach will be higher than weeks where no ES is received.
Conditions Studied
Interventions
- BEHAVIORAL Narrative Persuasion
- BEHAVIORAL Reciprocity
- BEHAVIORAL Personalized Feedback
- BEHAVIORAL Commitment
Study Locations (8)
Michigan
- University of Michigan - Ann Arbor
- Trinity Health Medical Group, Academic Family Medicine - Fruitport - Fruitport
- Helen DeVos Children's Hospital Emergency Department - Grand Rapids
- Muskegon Pediatrics - Muskegon
- HealthWest Youth and Family Services - Muskegon
- Hackley Community Care Medical Services - Muskegon
- Trinity Health - Community Health And Well-Being - Muskegon
- Trinity Health-Emergency Department - Muskegon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2023-02-28 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT05821205 shows while recruiting
NCT05821205 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 756-participant average among 9 other Violence in Adolescence trials with a reported enrollment target (68% lower).
The record links to 1 condition, with Violence in Adolescence appearing as the primary indexed condition, and to 4 interventions - of which Narrative Persuasion is the first listed.
NCT05821205 lists 8 locations in 1 state (Michigan).
Frequently Asked Questions
What is clinical trial NCT05821205 about?
NCT05821205 is a clinical study titled "Michigan Youth Violence Prevention Center: Building Evidence for Gun Violence Prevention - SafERteens Implementation". The purpose of this study is to determine the preliminary efficacy (via a micro-randomized trial \[MRT\] design) of augmenting Enhanced-Replicating Effective Program (E-REP) with engagement strategies to increase and sustain reach by healthcare providers (e.g., nurses, social workers) during impleme...
What is the current status of trial NCT05821205?
This trial is currently recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2023-02-28. Estimated completion is 2027-12.
What conditions does trial NCT05821205 study?
This clinical trial studies the following conditions: Violence in Adolescence.
What interventions are being tested in trial NCT05821205?
The interventions under investigation include: Narrative Persuasion (BEHAVIORAL), Reciprocity (BEHAVIORAL), Personalized Feedback (BEHAVIORAL), Commitment (BEHAVIORAL).
Who is sponsoring clinical trial NCT05821205?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05821205 being conducted?
This trial has 8 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Violence in Adolescence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05821205's enrollment target sits among peer trials
240 6th of 9 higher than 4 of 9 other Violence in Adolescence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Violence in Adolescence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Community Resiliency Collective Efficacy Intervention
RECRUITING · NA
-
Preventing Firearm Violence in Youth: A Hospital-based Prevention Strategy
RECRUITING · NA
-
The Healthy Families Bright Futures Program
RECRUITING · NA
-
Forging Hopeful Futures to Reduce Youth Violence
ACTIVE NOT RECRUITING · NA
-
Using Re-inforcement Learning to Automatically Adapt a Remote Therapy Intervention (RTI) for Reducing Adolescent Violence Involvement
ACTIVE NOT RECRUITING · NA
-
BrotherlyACT: A Tech-Enhanced Violence and Substance Use Intervention for Black Boys and Young Men
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI